Explore the latest breakthrough in malaria drugs targeting a unique protein essential for the parasite's survival and transmission.

The first-ever treatment for malaria in young babies and infants has been approved. On Tuesday, Novartis announced it had received approval for the treatment, Coartem Baby (known as Riamet Baby in ...

The first new malaria treatment in decades holds promise against rising drug resistance after Swiss drugmaker Novartis announced it was as effective at treating the disease as established treatments.

The medicine, called Coartem Baby (also known as Riamet Baby), was approved by Switzerland’s health agency, Swissmedic. HealthDay News — A new malaria treatment has been approved for newborns and ...

Malaria kills hundreds of thousands of children annually, yet there hasn’t been a major new drug to fight it in more than 25 years. Now, Novartis says it has one. The Swiss company said Wednesday that ...

Add Yahoo as a preferred source to see more of our stories on Google. Spread largely by mosquitos, Malaria causes a fever, headaches, confusion and muscle pains among other symptoms and can be fatal.

An international team of scientists has shed light on the development of the malaria parasite and have identified a unique protein essential for its survival and transmission, which offers a promising ...

NEW YORK (AP) — Researchers on Wednesday reported two promising new approaches to counteract malaria’s growing resistance to medication — one involving a new class of drugs. Man who lived rent-free in ...

Please provide your email address to receive an email when new articles are posted on . Pyronaridine, a common malaria drug, has been used for more than 50 years. The agent could be repurposed to ...

At the turn of the millennium, a new class of drugs derived from ancient Chinese herbal medicine revolutionized malaria care. Artemisinin's, as they're called, are based on extracts from the sweet ...